UE to their high rate of proliferation and profuse invasiveness, diffuse gliomas are invariably fatal. 49 Estimates of glioma proliferation are obtained by histopathological grading 34 and a variety of auxiliary methods. 11, 12 In contrast, brain invasiveness, an intrinsic property of diffuse gliomas, is not routinely evaluated. Diffuse gliomas are intraparenchymally metastatic tumors that invade the brain from the very onset of their development. 4 As a consequence, they are not amenable to complete surgical resection and defy other current therapeutic strategies.
es of rodent 36, 41 and human brain 31 were successfully used to measure and modulate the invasiveness of established glioma cell lines in experiments lasting from 2 to 7 days. Results of preliminary study have indicated that such short experimental protocols do not permit the researcher sensitively to detect differences in the invasiveness of gliomas retrieved at biopsy. To validate the use of the ISIS in longer term studies we first implanted various GBM cell lines of different known in vivo invasion potentials and followed their evolution for up to 29 days. In a second step, the method was adapted to analyze tumor tissue obtained at biopsy from 27 consecutive patients. The results indicate that the ISIS is an ex vivo system that permits the precise characterization of the invasiveness of individual gliomas.
Materials and Methods

Brain Slice Cultures
Cultures of brain slices obtained from 7-day-old C57/bl6 mice were prepared using a modification of a previously published method. 50 The mouse brains were removed and placed in 0.5 g/L D-glucose phosphate-buffered saline, the two cerebral hemispheres were separated, and 400-m-thick coronal slices were cut using a tissue chopper. Cut slices were transferred onto millicell membranes and kept in six-well plates above 1 ml of brain-slice medium (MEM containing 1 g/L D-glucose, 10% heat-inactivated FCS, 0.1 g/L transferrin, 16 g/L putrescine, 40 g/L N-selenium, 30 g/L triiodothyronine, 5 mg/L insulin, and 60 g/L progesterone). The brain slices were incubated at 37˚C in a humidified atmosphere containing 5% CO 2 . The medium was changed three times per week.
Established GBM Cell Lines
The two human GBM cell lines, GL15 6 and 8-MG-BA, 46 and the rodent C6 glioma cell line 3 were grown in glioma-cell medium (50% MEM and 50% Dulbecco modified Eagle medium), complemented with 10% FCS, 1 mM pyruvate, 33 mM glucose, 2 mM glutamine, and antibiotic agents) in a standard cell incubator. On confluence, the cells were trypsinized, centrifuged at 300 G for 10 minutes, and resuspended in 30 to 50 l of brain-slice medium to obtain 5 ϫ 10 4 cells/l for injection. To obtain spontaneously fluorescent cells, the tumor cells were infected with a GFP-recombinant (FOCHA [retrovirus developed at the Laboratoire Transfert Génétique et Oncologie Moléculaire]-GFP) Friend murine leukemia virus-based retroviral vector. 10 A single round of exposure to virus supernatant resulted in an infection covering 98% of bulk cells, as evidenced by the expression of GFP, which proved stable over time (2 years). The GFPexpressing cells exhibited a stable and unmodified phenotype, compared with nonmanipulated cells.
Human Biopsy Specimens and Cultures
Gliomas obtained during open surgery or stereotactic biopsy were retrieved in the operating room. One fragment was submitted for histological examination, a second one was snap-frozen and stored at Ϫ80˚C, and the third one was transferred within 20 minutes after retrieval to glioma-cell medium supplemented with antibiotic medications and maintained under a laminar flow hood. After removal of grossly necrotic and hemorrhaged areas, each fragment was cut into pieces (0.1-0.4 mm in diameter) by using two 26-gauge needles with the aid of an operating microscope. Care was taken not to mince or tease the tissue while cutting. The tumor content of the fragment to be grafted was confirmed by a frozen section or by subsequent analysis of the paraffin-embedded specimen. Diagnoses were established according to the World Health Organization 1993 classification. 34 To generate spheroids, tumor fragments and dissociated cells in glioma-cell medium were incubated in culture dishes, to which a base coat of 1% agar had been applied, for 12 to 24 days, until spheroids had formed. 16, 17, 40 The medium was changed every 5 days. Spheroids (0.1-0.4 mm in diameter) were selected for implantation with the aid of an inverted microscope equipped with a calibrated eye-piece graticule.
Fluorescent Dye Staining
For the purpose of staining, DiI was dissolved in 100% alcohol, sonicated for 10 minutes, and added to the medium to a final concentration of 30 g/ml. 40 Glioma fragments or spheroids were incubated in the dye-containing medium for 20 to 24 hours before implantation. Slices were fixed and mounted in a manner described later in this paper. In each case, tumor cells in several slices were also detected by immunolabeling for vimentin, although DiI-prelabeled specimens were preferred for measurements of invasion.
Cell Implantation
Injection of glioma cell lines and implantation of tumor tissue collected at biopsy into the cortex of the brain slices were performed with the aid of an operating microscope. Tumor cells were injected (0.1 l of cell suspension over 1.5 minutes) using a 0.5-l Hamilton syringe with a 230-m-wide outer-diameter needle affixed to the arm of a micromanipulator. Tumor fragments or spheroids were deposited onto the slice surface and gently pushed with the tip of a needle until the tumor tissue was well enveloped by the parenchyma of the slice. Slices containing injected cells were analyzed at 8 and 29 days, and tumor fragments or spheroids at 15 days after implantation.
Immunohistochemical Analysis
Slices fixed in 4% paraformaldehyde for 4 hours at 4˚C were removed from the filter membrane, washed in phosphate-buffered saline, and incubated overnight at 4˚C with monoclonal antibodies against HLA-ABC (concentration 1:200), and vimentin (concentration 1:200), or polyclonal antibodies against GFAP (concentration 1:400) and laminin (concentration 1:200). To detect bound antibodies, secondary anti-rabbit or anti-mouse immunoglobulin conjugated to fluorescein isothiocyanate (concentration 1:200) or to cyanidine-Cy3 (concentration 1:1000) was applied for 3 hours at room temperature. Double immunolabelings for tumor cells (HLA-ABC or vimentin) and blood vessel basal lamina (laminin) were also performed. The slices were mounted and covered.
Fluorescence Microscopy and Morphometry
Fluorescence microscopy and confocal microscopy were both performed. The images obtained were digitized and then processed using image analysis software. All areas containing invasive glioma cells were scanned by referring to nonoverlapping microscopic fields (ϫ 200; 0.4 mm 2 ), starting at the margin of the implant and moving away from it. Using optical sectioning, consecutive images throughout the slice thickness were acquired in each field to register all invasive cells that were present. For results, this procedure corresponded well to confocal sectioning of the slice thickness and image analysis of three-dimensional reconstituted images, but was considerably more time effective. In the case of GL15 cells, two types of invasion were separately quantified: invasion in the peritumoral zone, where tumor cells intermingled with host elements but were still in contact with the implant, and long-distance invasion of single detached cells. Coordinates of each field were recorded to map the invasion zone and invasion distance (mm), and the cell density of invasion (cells/ mm 2 ) was estimated using the point-measurement mode of the image analyzer. All invasive cells present were evaluated, yielding mean Ϯ standard deviations of 2300 Ϯ 1160 cells/GBM specimen (range 376-4766 cells/GBM specimen) and 310 Ϯ 244 cells/LGG specimen (range 66-852 cells/LGG specimen).
Statistical Analysis
Statistical analysis was performed using two commercially available software packages. In each case, the maximum distance and cell density of invasion were assessed as the 90th percentile calculated from the distribution of all recorded invasive cells. Estimates of maximum invasion were preferred to median or mean values because distributions were markedly asymmetrical and because the most aggressive tumor cell subpopulations could be expected to determine the invasive behavior of the tumor in vivo. 16 Two groups were compared using the Mann-Whitney, Wald-Wolfowitz, or Wilcoxon tests, and three or more groups were compared using the KruskalWallis test followed by the Bonferroni-Dunn posttest. Results provided in the text are presented as the means Ϯ standard deviations. The level of significance was set at 0.05.
Sources of Supplies and Equipment
The McIllwain tissue chopper was acquired from Mickle Laboratory (Guildford, UK) and the Millicell-CM membranes from Millipore (Saint Quentin, France). The MEM was provided by Gibco (Cergy, France), and the D-glucose, heat-inactivated FCS, transferrin, putrescine, N-selenium, triiodothyronine, insulin, and progesterone were all purchased from Sigma Chemical Co. (Saint Quentin, France). Life Technologies (Grand Island, NY) provided the Dulbecco modified Eagle medium, and Molecular Probes (Eugene, OR) the DiI. The micromanipulator used for cell implantation was purchased from Narashige, Inc. (Tokyo, Japan). The monoclonal antibodies against HLA-ABC and vimentin, and the polyclonal antibody against GFAP as well as the Vectashield coverslips were acquired from Dako Corp. (Glostrup, Denmark). The polyclonal antibody against laminin was purchased from Sigma. The fluorescein isothiocyanate was obtained from Vector Laboratories (Burlingame, CA) and the cyanidine-Cy3 from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA). Carl Zeiss, Inc. (Oberkochen, Germany) manufactured the Axioplan-2 microscope, the Axiovert 135M microscope, and the KS 400 (version 3.0) image analysis software. Images were digitized using a CoolSNAP camera purchased from Roper Scientific (Tucson, AZ). Inspector software was purchased from Matrox Imaging (Rungis, France). Statistical analysis was performed with the aid of both StatView F 4-11 (Abacus Concepts, Inc., Berkeley, CA) and InStat (GraphPad Software, Inc., San Diego, CA) software.
Results
Confocal microscopy demonstrated that, after 2 to 4 weeks in culture, the brain slices retained good preservation of their cytoarchitecture and vascular network. Glioma cells did not migrate on the slice surface, but rather within the slice thickness.
Established Glioma Cell Lines
Two tumor cell lines, rodent C6 2 and human 8-MG-BA, were observed to develop in the brain slice as spherical noninvasive tumor masses. This behavior was similar to that exhibited by these cell lines in vivo; following injection into the rat brain, C6 and human 8-MG-BA have both displayed few signs of invasion (unpublished data). There were practically no invading cells, no matter what time point was studied ( Fig. 1A and B) . In sharp contrast, human GL15 cells, which form very invasive tumors when grafted into the rat brain, 26 were similarly invasive in the brain slice ( Fig. 1C and D) . Numerous cells diffusely infiltrated the peritumoral zone. The area of this invasion zone progressively increased from Day 8 (0.074 Ϯ 0.016 mm 2 ; seven brain slices) to Day 29 (0.14 Ϯ 0.04 mm 2 ; nine brain slices) (p Ͻ 0.002; Fig. 1C and D, respectively) . In addition, cells that had migrated a long distance were present at all time points studied. The maximum migration distances of these cells also increased from Day 8 (0.51 Ϯ 0.106 mm) to Day 29 (0.92 Ϯ 0.18 mm; p Ͻ 0.002). Cells migrating long distances were commonly seen to be oriented in parallel to blood vessels, within the slice thickness ( Fig. 2A) contact with their basal lamina, as demonstrated by laminin immunostaining (Fig. 2B) . The reproducibility of the system proved satisfactory because the coefficients of variation of both parameters of invasion-that is, area of this invasion zone and maximum migration distances-were between 19 and 29%.
Glioma Biopsy Specimens
The ISIS allowed us to establish ex vivo tumor growth in 19 (83%) of 23 cases of diffuse gliomas, including 12 of 15 GBMs and seven of eight LGGs (Grade II or III oligodendrogliomas and oligoastrocytomas). In addition, three nonneuroectodermal tumors (two squamous-cell lung carcinomas that had metastasized to the brain and one meningioma) and one specimen of reactive gliosis (vasculitis-associated perinecrotic gliosis) were grown. In each case, the number of slices with successfully established implants varied between two and 15 (mean 10 Ϯ 4 slices), providing proportions of success ranging from 33 to 100% (mean 76 Ϯ 18%).
All diffuse gliomas (19 of 19 lesions) invaded the brain slice, whereas invasion was not associated with any nonneuroectodermal tumors or nonneoplastic gliosis. Gliomas invaded as single cells that spread into the otherwise unperturbed architecture of the slice (Fig. 3) . Intraspecimen variability, as measured by the coefficients of variation of the two invasion estimates, was between 28 and 73%.
Quantitative intergroup analysis between diffuse gliomas revealed that GBMs were more invasive than LGGs. On average, the maximum distance and cell density of invasion were, respectively, two and four times greater for GBMs than for LGGs (Fig. 4A) . Plotting out invasion cell densities against invasion distances for each group showed that the mean invasion cell density was consistently higher for GBMs than for LGGs throughout the invasion area (p Ͻ 0.0001; Fig. 4B ).
Quantitative intragroup analysis additionally demonstrated heterogeneity among GBMs and LGGs. Significant differences in maximum invasion distances (p Ͻ 0.0001) were detected within both GBMs and LGGs (Fig. 4A) . Furthermore, tumors exhibiting similar invasion distances could differ significantly in invasion cell density (data not shown).
To determine whether highly invasive cells could preferentially be located at the tumor-parenchyma interface, rather than in more centrally located areas, the invasiveness of specimens selectively sampled from the periphery and from deeper portions of the tumor (as confirmed by histological examination) was compared in six specimens (three GBMs and three LGGs). Maximum invasion distances were significantly higher for peripheral tumor cells in two of three GBMs-2.2 mm compared with 1.1 mm (p Ͻ 0.0001) and 1.1 mm compared with 0.7 mm (p Ͻ 0.02)-and in two of three LGGs-1 mm compared with 0.6 mm (p Ͻ 0.02) and 0.5 mm compared with 0.3 mm (p Ͻ 0.03)-whereas in the two other specimens peripheral and centrally located cells displayed similar values. These differences were mainly due to the presence at the periphery of a fraction of highly invasive cells representing 20 to 30% of all invasive cells (Fig. 5) .
Spheroids were successfully established and implanted from six (50%) of 12 GBMs and from two (33%) of six
LGGs. The maximum invasion distance of spheroids was lower by 14 to 54% in all eight cases (p Ͻ 0.02), and the maximum invasion cell density was lower by 17 to 60% in seven of eight specimens (p Ͻ 0.03; Wilcoxon test) in comparison with paired directly grafted specimens. Coefficients of variation of the maximum invasion distance and maximum invasion cell density in the spheroid experiments (44 Ϯ 11% and 37 Ϯ 18%, respectively) were strikingly similar to the coefficients of variation calculated for the corresponding directly implanted specimens (43 Ϯ 8% and 37 Ϯ 16%, respectively).
Discussion
We demonstrated the efficiency of an ISIS by using mouse brain slices to analyze the invasive behavior of human glioma cells obtained from biopsy specimens. The major advantages of this approach consist of the following: 1) the high rate of successfully established specimens of gliomas of different histological grades (Ͼ 80%); 2) the use of a specific organotypical invasion substrate; 3) the precise quantification of invasion that may allow the characterization of individual tumors; and 4) the relative technical simplicity of the procedure.
Importance of an Organ-Specific Environment for Glioma Invasion
In vitro techniques designed to analyze glioma invasion are under intensive investigation. 47 They should meet a number of requirements, 32, 47 such as technical feasibility, preservation of the cell diversity of the tumor, reproduction of in vivo phenomena, and quantification. These requirements, however, have turned out to be difficult to reconcile in a single design. The choice of an organ-specific invasion substrate may be the most critical prerequisite for the validity of a glioma invasion assay. 1, 14 Simplified in vitro systems are likely to be innately incapable of simulating interactions between tumor cells and the host environment. 32, 44 At best, monolayer migration and transmigration assays only reproduce isolated aspects of glioma invasion. 32 For instance, meningioma cells that do not, as a rule, invade the brain, 16 migrate faster than gliomas on plastic surfaces 18 and can be very invasive when tested in Boyden chambers. 48 Both monolayer and filter-based assays have been criticized for the use of migration or transmigration substrates of limited distribution in the human brain. 31, 47 Another obvious limitation of these assays stands out in the face of results proposing that "cross talk" between tumor and normal cells may be instrumental to glioma cell invasion. 25 Confrontation assays performed using rat fetal brain aggregates, a more organ-specific substrate, have proved superior to most other in vitro techniques. 32 Nevertheless, confrontation assays are dominated by cell destruction and replacement and proteolytic degradation of the substrate away from the tumor, rather than by single cell invasion. 7, 16, 33, 40 As a consequence, invasion in confrontation assays is assessed semiquantitatively 7, 16 or by linear regression models of the substrate destruction. 33, 40, 45 These methods have not permitted formal statistical comparisons between tumors of similar 40 or different 16 grades. In contrast, as also demonstrated by a study on clonal glioma cells, 31 examining single invasive cells with the aid of the ISIS permits a detailed quantitative analysis.
Importance of Avoiding Preculturing Steps
The inevitable glioma cell incubation, expansion, and passaging steps 9, 28, 49 have both limited the number of successfully grown specimens (generally Ͻ 50%) 19 and opened up the possibility of undesired clonal selection. 39 Even low passage numbers (Ͻ five passages) were shown to affect differentiation 42 and the cell clone repertoire, 27 and to reduce up to 20-fold the invasiveness of glioma cells. 43 Glioma spheroid generation is also not exempt from cell selection. Although glioma cells in spheroids were shown to preserve certain characteristics of the original tumor, such as DNA ploidy, 5 clonal deletion has recently been demonstrated more often, 30 and that is likely due to the intensive cell turnover, as well as cell shedding during the spheroid formation phase. 5 In our hands, spheroids were less invasive than directly grafted fragments. Apart from clonal cell selection, there are other possible explanations for this unexpected result. The microenvironment of glioma-derived spheroids is characterized by cell packing and extensive cell-to-cell contacts affected by formation of gap junctions. 38 In an in vitro assay performed to analyze cell migration out of spheroids, it was demonstrated that the migratory capacities of the tumor cells were inversely correlated with the number of gap junctions present in the spheroid. These results suggest that cell packing in glioma spheroids, an artifact of the forced cell cooperation in this model, may hamper detachment from the neighboring cells, a critical early step in invasion. 25 In addition, glioma cells in spheroids have been shown to express integrin arrays different from those in the original tumor and to switch to massive production of extracellular matrix molecules. 43 Although the effects of such a mesenchymal transdifferentiation on invasion have not been studied, integrins are involved in glioma invasion. We initially resorted to glioma spheroids with the aim to standardize our invasion assay more stringently. The presence of intraspecimen variation in spheroid experiments, however, was not lower than that observed in ISIS experiments, suggesting that variability of invasiveness was mostly due to genuine intratumoral heterogeneity. 40 Direct implantation of glioma fragments after careful verification of their tumor-cell content has been successfully used in in vivo invasion studies in which human astrocytomas were grafted into the rat brain. 29, 51 Our results indicate that, with an appropriate invasion substrate, selected fragments can be used in an ex vivo invasion assay. 
Invasiveness of Gliomas in Relationship to Tumor Grade
When confronted with an organ-specific in vitro environment, glioma cells of different origins exhibited different migratory drives. In the ISIS, the invasiveness of glioma cell lines was in good agreement with results obtained in vivo. 2, 26 Quantified analysis of human glioma biopsy specimens documented intergrade, intragrade, and intraspecimen differences of invasiveness. Grade IV GBMs were conspicuously more invasive than LGGs, in accordance with data from another confrontation assay study. 16 Within the LGG group, however, Grade III tumors were not more invasive than Grade II tumors. That the migration capacities of glioma cells could be directly proportional to tumor grade is intuitively acceptable; however, arguments in support of this thesis are not so strong. 8, 9, 20, 49 By joining evidence provided by clinics and in vitro studies, Giese and coworkers [23] [24] [25] and McDonough, et al., 38 have pointed out that glioma invasiveness does not necessarily share a linear relationship with their histological malignancy grade. We are currently examining larger groups of GBMs and LGGs to look for histological features that may be associated with this heterogeneity. Because invasiveness can vary greatly from one tumor to another, 40 it has long been anticipated that invasiveness may be correlated with the clinical course of patients. 5 Exploration of this hypothesis, however, has been hampered by the insufficient precision of invasion assays. 40, 52 Using the ISIS, the precise quantification of distance and cell density of invasion and the combination thereof allowed us to analyze individual glioma invasiveness in greater detail than that allowed by any other in vitro method. 16, 40 Thus, the ISIS may help to establish whether invasion per se is a determinant of the prognosis of patients with gliomas.
The ISIS as a Tool to Isolate and Study Invasive Glioma Cells
It has been suggested that invasive capacities may be particularly present in some DIGCs. 49 Because DIGCs are one major source of recurrences following treatment, 49 specific characterization of these cells is most relevant to strategies of glioma therapy. 22, 38 Malignant gliomas evolve through selection of cell clones with growing genetic instability. 35 One potential correlate of this concept of clonal evolution is that DIGCs correspond to clones with a specific genetic background that have acquired the capacity to move actively, detach themselves from neighboring cells in the tumor mass, interact with the extracellular matrix and cells of the host, and proteolytically modify their environment (see Discussion in other articles 22, 25, 37 ). Several results obtained using the ISIS indicate that this method readily allows the researcher to differentiate DIGCs from cells in the tumor mass. Following implantation, some cells were more apt to invade, whereas others remained in the implant. Invasive cells were clearly capable of interacting with the basal lamina of blood vessels, a known specific substrate of glioma dissemination in vivo. Topographically, such highly motile cells were present at the tumor margin, rather than in more centrally located areas in four of six tumors. Presumptive DIGCs isolated from the tumor margin have been shown to grow twice as fast as cells taken from the tumor mass, 49 but the expected differences in migration velocities between the two types of cells could not be established in the same monolayer migration study. In contrast, the use of the ISIS seemed to validate the hypothesis of a center-to-periphery gradient of invasiveness in diffuse gliomas. The ISIS may, therefore, help to isolate (by microdissection) DIGCs from the rest of the tumor cells and perform a specific analysis of their properties. In this way, the ISIS could allow us to decipher the driving forces at work in glioma invasion and, eventually, to design targeted antiinvasive therapeutics.
Conclusions
Organotypical cultures of brain slices support the invasive growth of both clonal and freshly isolated human glioma cells. Using the ISIS, gliomas invade as single cells that follow preferential pathways of dissemination, similar to those present in the human brain. Measurements of single invasive cells allow detailed characterization of individual glioma invasiveness. These advantageous features of the ISIS seem to set it apart as the assay of choice for studies on the mechanisms, clinical and pathological correlates, and pharmacological modification of glioma invasion.
